Celixir provides update on ongoing clinical programme with lead therapeutic candidate CLXR-001 First patient successfully dosed in cardiomyopathy study Stratford-upon-Avon, UK: July, 6 2019 – Celixir, a privately-owned company discovering and developing life-saving advanced therapies, announces an update to its ongoing clinical […]